Website
ALS Ltd.Telephone
61.7.3367.7900
Address
Level 9B, 25 King Street Bowen Hills Brisbane, Queensland (QLD) 4006
Description
ALS Ltd. engages in the provision of analytical and testing services businesses and partnerships. It operates through the following segments: Life Sciences, Commodities, Industrial, and Other. The Life Sciences segment is involved in analytical testing data to assist consulting and engineering firms, industry, and governments in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health. The Commodities segment includes assaying and analytical testing and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry such as coal sampling, analysis and certification, and formation evaluation services. The Industrial segment focuses on energy, resources, and infrastructure sectors with asset care and tribology testing services. The company was founded in 1863 and is headquartered in Brisbane, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 11.75 - 16.04
Trade Value (12mth)
AU$3,388,674.00
1 week
3.09%
1 month
6.24%
YTD
18.84%
1 year
25.04%
All time high
16.04
EPS 3 yr Growth
64.60%
EBITDA Margin
25.70%
Operating Cashflow
$350m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
12.40
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
488m
HALO Sector
Industrials
Next Company Report Date
27-May-25
Ex Dividend Date (est.)
27-Nov-24
Next Dividend Pay Date (est.)
19-Dec-24
Reporting Currency
AUD
Short Sell (% of issue)
1.98
Date | Announcements |
---|---|
19 November 24 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
19 November 24 |
Dividend/Distribution - ALQ
×
Dividend/Distribution - ALQ |
19 November 24 |
ALS H1 FY25 release
×
ALS H1 FY25 release |
19 November 24 |
ALS H1 FY25 Investor Presentation
×
ALS H1 FY25 Investor Presentation |
12 November 24 |
Link to H1 FY25 results investor briefings
×
Link to H1 FY25 results investor briefings |
22 October 24 |
ALS announces departure of Andreas Jonsson, EGM Food & Pharm
×
ALS announces departure of Andreas Jonsson, EGM Food & Pharm |
25 September 24 |
ALS announces Dayna Field as General Counsel and Company Sec
×
ALS announces Dayna Field as General Counsel and Company Sec |
19 September 24 |
ALS Trading update
×
ALS Trading update |
28 August 24 |
Appendix 3C
×
Appendix 3C |
13 August 24 |
Resignation of Company Secretary & General Counsel
×
Resignation of Company Secretary & General Counsel |
08 August 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
02 August 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
02 August 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
31 July 24 |
Chairman's 2024 AGM Address
×
Chairman's 2024 AGM Address |
31 July 24 |
Managing Director & CEO 2024 AGM Address
×
Managing Director & CEO 2024 AGM Address |
31 July 24 |
Results of Meeting
×
Results of Meeting |
31 July 24 |
2024 AGM video
×
2024 AGM video |
25 July 24 |
ALS confirms commencement of legal proceedings
×
ALS confirms commencement of legal proceedings |
24 July 24 |
Macquarie ESG Summit Presentation
×
Macquarie ESG Summit Presentation |
04 July 24 |
Securities Trading Policy
×
Securities Trading Policy |
04 July 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
02 July 24 |
Application for quotation of securities - ALQ
×
Application for quotation of securities - ALQ |
01 July 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
26 June 24 |
ALS 2024 Sustainability Report
×
ALS 2024 Sustainability Report |
26 June 24 |
ALS Releases 2024 Sustainability Report
×
ALS Releases 2024 Sustainability Report |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.